Taken together, it is conceivable that the HPSE gene enhancer plays an important role in progression of the disease before diagnosis, and that the risk of multiple myeloma being diagnosed at later stages of the disease is higher in individuals with the AA genotype. Here, HPSE is linked to AL amyloidosis.